ACQ‐CMH‐104 |
WHOQOL‐Bref |
WHOQOL‐Bref |
Portugal |
Psychiatric patients participating in community mental health organisations |
129 |
Pearson coefficient |
0.60 |
[66] |
ACQ‐CMH‐104 |
RAS-P |
Recovery assessment scale |
Portugal |
Psychiatric patients participating in community mental health organisations |
92 |
Pearson coefficient |
0.46 |
[66] |
ASCOT |
EQ-5D-3L |
EQ-5D-3L |
UK |
Day care for older people |
224 |
Spearman Rank |
0.47 |
[68] |
ASCOT |
ICECAP-O |
ICECAP-O |
UK |
Older social care users |
205 |
Spearman Rank |
0.81 |
[21] |
ASCOT |
EQ-5D-5L |
EQ-5D-5L |
UK |
Older social care users |
205 |
Spearman Rank |
0.63 |
[21] |
ASCOT |
EQ-5D-VAS |
EQ-5D-VAS |
UK |
Older social care users |
205 |
Spearman Rank |
0.64 |
[21] |
ASCOT |
Barthel Index |
Barthel Index |
UK |
Older social care users |
205 |
Spearman Rank |
0.45 |
[21] |
ASCOT |
GDS-15 (negative correlation) |
GDS-15* |
UK |
Older social care users |
205 |
Spearman Rank |
0.69 |
[21] |
ASCOT |
OPQOL-13 |
OPQOL-13 |
UK |
Older social care users |
205 |
Spearman Rank |
0.76 |
[21] |
ASCOT |
SWLS |
SWLS |
UK |
Older social care users |
205 |
Spearman Rank |
0.74 |
[21] |
ASCOT |
Cantril’s Ladder |
Cantril’s Ladder |
UK |
Older social care users |
205 |
Spearman Rank |
0.66 |
[21] |
ASCOT |
Older People’s Quality-of-Life brief questionnaire |
OPQoL-Brief |
Australia |
Community-dwelling older people receiving aged care services |
87 |
Spearman Rank |
0.58 |
[69] |
ASCOT |
EQ-5D-3L |
EQ-5D-3L |
UK |
Older people receiving publicly funded home care services |
301 |
Pearson correlation |
0.40 |
[70] |
ASCOT |
EQ-5D-5L |
EQ-5D-5L |
Australia |
Older adults in a day rehabilitation facility |
22 |
Spearman Rank |
0.24 |
[71] |
ASCOT |
Brief Older People’s Quality of Life |
OPQOL-brief |
Australia |
Older adults in a day rehabilitation facility |
22 |
Spearman Rank |
0.38 |
[71] |
ASCOT |
EQ-5D-3L |
EQ-5D-3L |
UK |
Older home care residents |
301 |
Pearson coefficient |
0.41 |
[52] |
ASCOT |
GHQ-12 (negative correlation) |
GHQ-12* |
UK |
Older home care residents |
301 |
Pearson coefficient |
0.58 |
[52] |
ASCOT |
Control and autonomy subscale of CASP-12 |
CASP-12 |
UK |
Older home care residents |
301 |
Pearson coefficient |
0.58 |
[52] |
ASCOT |
EQ-5D-3L |
EQ-5D-3L |
UK |
General population |
200 |
Gradient |
0.98 |
[73] |
ASCOT |
EQ-5D-3L |
EQ-5D-3L |
Netherlands |
Frail older adults living at home |
190 |
Spearman Rank |
0.41 |
[74] |
ASCOT |
ICECAP-O |
ICECAP-O |
Netherlands |
Frail older adults living at home |
190 |
Spearman Rank |
0.41 |
[74] |
ASCOT |
EQ-5D-3L |
EQ-5D-3L |
UK |
Community-based adult social care service users |
748 |
Spearman Rank |
0.37 |
[72] |
ASCOT |
ICECAP-O |
ICECAP-O |
UK |
Community-based adult social care service users |
748 |
Spearman Rank |
0.67 |
[72] |
ASCOT |
ICECAP-A |
ICECAP-A |
UK |
Community-based adult social care service users |
748 |
Spearman Rank |
0.62 |
[72] |
ASCOT-Carer |
Carer Experience Scale (CES) |
CES |
UK |
Social care recipients |
376 |
Spearman Rank |
0.58 |
[76] |
ASCOT-Carer |
Carer Strain Index (negative correlation) |
CSI |
UK |
Social care recipients |
384 |
Spearman Rank |
− 59 |
[76] |
ASCOT-Carer |
EQ-5D-3L |
EQ-5D-3L |
UK |
Social care recipients |
382 |
Spearman Rank |
0.34 |
[76] |
ASCOT-Carer |
QoL (single item using a 7-point Likert scale) |
QoL |
UK |
Social care recipients |
384 |
Spearman Rank |
0.62 |
[76] |
ICECAP-A |
Assessment of Quality of Life |
AQoL-8D |
Australia, Canada, Germany, Norway, UK, USA |
Patients with seven chronic conditions and a sample of the ‘healthy’ public |
8022 |
Spearman Rank |
0.80 |
[20] |
ICECAP-A |
EQ-5D-5L |
EQ-5D-5L |
Australia, Canada, Germany, Norway, UK, USA |
Patients with seven chronic conditions and a sample of the ‘healthy’ public |
8022 |
Spearman Rank |
0.60 |
[20] |
ICECAP-A |
15D |
15D |
6 countries (MIC) |
Representative healthy cohort and from patients in eight clinical areas |
6756 |
Pearson coefficient (average of correlations among factors) |
0.50 |
[24] |
ICECAP-A |
AQoL-8D |
AQoL-8D |
6 countries (MIC) |
Representative healthy cohort and from patients in eight clinical areas |
6756 |
Pearson coefficient (average of correlations among factors) |
0.31 |
[24] |
ICECAP-A |
EQ-5D-5L |
EQ-5D-5L |
6 countries (MIC) |
Representative healthy cohort and from patients in eight clinical areas |
6756 |
Pearson coefficient (average of correlations among factors) |
0.49 |
[24] |
ICECAP-A |
HUI-3 |
HUI-3 |
6 countries (MIC) |
Representative healthy cohort and from patients in eight clinical areas |
6756 |
Pearson coefficient (average of correlations among factors) |
0.32 |
[24] |
ICECAP-A |
SF-6D |
SF-6D |
6 countries (MIC) |
Representative healthy cohort and from patients in eight clinical areas |
6756 |
Pearson coefficient (average of correlations among factors) |
0.47 |
[24] |
ICECAP-A |
HUI-3 |
HUI-3 |
Australia, Canada, Germany, Norway, UK, and USA |
Individuals with self-reported depression |
917 |
R2
|
0.46 |
[79] |
ICECAP-A |
SF-6D |
SF-6D |
Australia, Canada, Germany, Norway, UK, and USA |
Individuals with self-reported depression |
917 |
R2
|
0.36 |
[79] |
ICECAP-A |
15D |
15D |
Australia, Canada, Germany, Norway, UK, and USA |
Individuals with self-reported depression |
917 |
R2
|
0.42 |
[79] |
ICECAP-A |
Assessment of Quality-of-Life Multi-Attribute Utility Instrument |
AQoL-8D |
Australia, Canada, Germany, Norway, UK, and USA |
Individuals with self-reported depression |
917 |
R2
|
0.58 |
[79] |
ICECAP-A |
EQ-5D-5L |
EQ-5D-5L |
Australia, Canada, Germany, Norway, UK, and USA |
Individuals with self-reported depression |
917 |
R2
|
0.34 |
[79] |
ICECAP-A |
EQ-5D-5L |
EQ-5D-5L |
Canada |
Patients with Spinal Cord Injury |
364 |
Path analysis |
0.37 |
[78] |
ICECAP-A |
Assessment of Quality-of-Life Multi-Attribute Utility Instrument |
AQoL-8D |
Canada |
Patients with Spinal Cord Injury |
364 |
Path analysis |
0.54 |
[78] |
ICECAP-A |
Leeds Dependence Questionnaire (negative correlation) |
LDQ* |
UK |
Individuals receiving opiate substitution treatment for more than 12 months |
83 |
Pearson coefficient |
0.48 |
[34] |
ICECAP-A |
Social Satisfaction Questionnaire |
SSQ |
UK |
Individuals receiving opiate substitution treatment for more than 12 months |
83 |
Pearson coefficient |
0.43 |
[34] |
ICECAP-A |
EQ-5D-3L |
EQ-5D-3L |
UK |
Women with lower urinary tract symptoms |
478 |
Pearson coefficient |
0.53 |
[23] |
ICECAP-A |
EQ-5D-3L |
EQ-5D-3L |
UK |
Knee pain patients in primary care |
500 |
Spearman Rank |
0.49 |
[27] |
ICECAP-A |
36-Item Short Form Health Survey |
SF-36 |
Australia, Canada, Germany, Norway, UK, USA |
Patients with seven chronic conditions and a sample of the ‘healthy’ public |
8022 |
R2
|
0.57 |
[116] |
ICECAP-A |
36-Item Short Form Health Survey |
AQoL-8D |
Australia, Canada, Germany, Norway, UK, USA |
Patients with seven chronic conditions and a sample of the ‘healthy’ public |
8022 |
R2
|
0.71 |
[116] |
ICECAP-A |
EQ-5D-5L |
EQ-5D-5L |
Germany |
Healthy Samples and Seven Health Condition Groups |
1212 |
Pearson coefficient |
0.62 |
[108] |
ICECAP-A |
SWLS |
SWLS |
Germany |
Healthy Samples and Seven Health Condition Groups |
1212 |
Pearson coefficient |
0.66 |
[108] |
ICECAP-A |
SF-6D |
SF-6D |
Germany |
Healthy Samples and Seven Health Condition Groups |
1212 |
Pearson coefficient |
0.64 |
[108] |
ICECAP-A |
Depression, Anxiety and Stress Scale |
DASS-D |
4 English speaking countries of MIC |
Individuals with depression |
617 |
R2
|
? |
[38] |
ICECAP-A |
Kessler Psychological Distress Scale |
K10 |
4 English speaking countries of MIC |
Individuals with depression |
617 |
R2
|
? |
[38] |
ICECAP-A |
EQ-5D-3L |
EQ-5D-3L |
China |
General population |
975 |
Polychoric correlation coefficient |
0.45 |
[107] |
ICECAP-O |
EQ-5D-3L |
EQ-5D-3L |
UK |
General population aged 65 and over |
315 |
Chi-squared tests |
0.42 (Attachment), 0.008** (Security), < 0.001** (Role), < 0.001** (Enjoyment), < 0.001** (Control) |
[40] |
ICECAP-O |
EQ-5D |
EQ-5D-3L |
Australia |
Patients from an outpatient day rehabilitation unit |
80 |
Spearman Rank |
0.44 |
[22] |
ICECAP-O |
CTM-3 |
CTM-3 |
Australia |
Patients from an outpatient day rehabilitation unit |
82 |
Spearman Rank |
0.23 |
[22] |
ICECAP-O |
EQ-5D |
EQ-5D-3L |
Canada |
Participants visiting the Vancouver Falls Prevention Clinic |
215 |
Spearman Rank |
0.47 |
[25] |
ICECAP-O |
EQ-5D-3L |
EQ-5D-3L |
UK |
Aged over 65 years, requiring a hospital visit and/or care home resident, and recruited to one of 3 studies forming the Medical Crisis in Older People (MCOP) programme |
584 |
R2
|
0.35 |
[26] |
ICECAP-O |
EQ-5D-5L |
EQ-5D-5L |
UK |
Older social care users |
207 |
Spearman Rank |
0.68 |
[21] |
ICECAP-O |
EQ-5D-VAS |
EQ-5D-VAS |
UK |
Older social care users |
208 |
Spearman Rank |
0.66 |
[21] |
ICECAP-O |
Barthel Index |
Barthel Index |
UK |
Older social care users |
209 |
Spearman Rank |
0.49 |
[21] |
ICECAP-O |
GDS-15 (negative correlation) |
GDS-15* |
UK |
Older social care users |
210 |
Spearman Rank |
0.73 |
[21] |
ICECAP-O |
OPQOL-13 |
OPQOL-13 |
UK |
Older social care users |
211 |
Spearman Rank |
0.80 |
[21] |
ICECAP-O |
SWLS |
SWLS |
UK |
Older social care users |
212 |
Spearman Rank |
0.82 |
[21] |
ICECAP-O |
Cantril’s Ladder |
Cantril’s Ladder |
UK |
Older social care users |
213 |
Spearman Rank |
0.74 |
[21] |
ICECAP-O |
EQ-5D-5L |
EQ-5D-5L |
UK |
People aged 70 and older |
516 |
Spearman Rank |
0.63 |
[90] |
ICECAP-O |
Barthel Index |
Barthel Index |
Germany |
Nursing Home Residents with Dementia |
95 |
Pearson coefficient |
0.72 |
[18] |
ICECAP-O |
EQ-5D-3L |
EQ-5D-3L |
Germany |
Nursing Home Residents with Dementia |
95 |
Pearson coefficient |
0.69 |
[18] |
ICECAP-O |
ADRQL |
ADRQL |
Germany |
Nursing Home Residents with Dementia |
95 |
Pearson coefficient |
0.53 |
[18] |
ICECAP-O |
EQ-5D-3L |
EQ-5D-3L |
Australia |
Older people following surgery for hip fracture |
87 |
Spearman Rank |
0.53 |
[93] |
ICECAP-O |
Western Ontario and McMaster Universities |
WOMAC |
UK |
Osteoarthritis patients requiring joint replacement |
105 |
R2
|
0.40 |
[94] |
ICECAP-O |
EQ-5D-3L |
EQ-5D-3L |
UK |
Participants aged 65 years and over with an intracapsular fracture of the hip |
113 |
Pearson coefficient |
0.34 |
[95] |
ICECAP-O |
Oxford Hip Score |
OHS |
UK |
Participants aged 65 years and over with an intracapsular fracture of the hip |
113 |
Pearson coefficient |
0.38 |
[95] |
ICECAP-O |
Barthel Index measure of activities of daily living |
Barthel Index |
Spain |
Nursing professionals serving as proxy respondents for dementia patients |
217 |
Not reported |
0.68 |
[87] |
ICECAP-O |
Alzheimer’s Disease-Related Quality of Life |
ADRQL |
Spain |
Nursing professionals serving as proxy respondents for dementia patients |
217 |
Not reported |
0.61 |
[87] |
ICECAP-O |
EQ-5D extended with a cognitive dimension |
EQ-5D + C |
Spain |
Nursing professionals serving as proxy respondents for dementia patients |
217 |
Not reported |
0.62 |
[87] |
ICECAP-O |
EQ-5D-3L |
EQ-5D-3L |
Netherlands |
Frail older adults living at home |
190 |
Spearman Rank |
0.63 |
[74] |
ICECAP-O |
Parkinson’s specific QoL |
PDQ-39 |
? |
People with Parkinson’s |
1023 |
Not reported |
0.53 |
[96] |
ICECAP-O family version |
EQ-5D family version |
EQ-5D family version |
Netherlands |
Nursing professionals of psycho-geriatric elderly |
96 |
Pearson coefficient |
0.57 |
[92] |
ICECAP-O family version |
EQ-VAS family version |
EQ-VAS family version |
Netherlands |
Family members of psycho-geriatric elderly |
68 |
Pearson coefficient |
0.43 |
[92] |
ICECAP-O nursing version |
EQ-5D nursing version |
EQ-5D nursing version |
Netherlands |
Nursing professionals of psycho-geriatric elderly |
96 |
Pearson coefficient |
0.48 |
[92] |
ICECAP-O nursing version |
EQ-VAS nursing version |
EQ-VAS nursing version |
Netherlands |
Family members of psycho-geriatric elderly |
68 |
Pearson coefficient |
0.55 |
[92] |
OxCAP-MH |
EQ-5D-index UK |
EQ-5D-index UK |
Austria |
Patients in socio-psychiatric services |
159 |
Spearman Rank |
0.67 |
[17] |
OxCAP-MH |
EQ-5D-index DE |
EQ-5D-index DE |
Austria |
Patients in socio-psychiatric services |
160 |
Spearman Rank |
0.66 |
[17] |
OxCAP-MH |
EQ-5D VAS |
EQ-5D VAS |
Austria |
Patients in socio-psychiatric services |
161 |
Spearman Rank |
0.58 |
[17] |
OxCAP-MH |
BSI-18 |
BSI-18 |
Austria |
Patients in socio-psychiatric services |
162 |
Spearman Rank |
− 67 |
[17] |
OxCAP-MH |
WHOQOL-BREF Physical health |
WHOQOL-BREF Physical health |
Austria |
Patients in socio-psychiatric services |
163 |
Spearman Rank |
0.69 |
[17] |
OxCAP-MH |
WHOQOL-BREF Psychological |
WHOQOL-BREF Psychological |
Austria |
Patients in socio-psychiatric services |
164 |
Spearman Rank |
0.75 |
[17] |
OxCAP-MH |
WHOQOL-BREF Social relationships |
WHOQOL-BREF Social relationships |
Austria |
Patients in socio-psychiatric services |
165 |
Spearman Rank |
0.50 |
[17] |
OxCAP-MH |
WHOQOL-BREF Environment |
WHOQOL-BREF Environment |
Austria |
Patients in socio-psychiatric services |
166 |
Spearman Rank |
0.69 |
[17] |
OxCAP-MH |
Mini-ICF-APP |
Mini-ICF-APP |
Austria |
Patients in socio-psychiatric services |
167 |
Spearman Rank |
− 0.47 |
[17] |
OxCAP-MH |
Global Assessment of Functioning |
GAF |
Austria |
Patients in socio-psychiatric services |
168 |
Spearman Rank |
0.35 |
[17] |
OxCAP-MH |
EQ-5D-3L Utility |
EQ-5D-3L |
UK |
Patients with psychosis |
172 |
Pearson coefficient |
0.45 |
[19] |
OxCAP-MH |
EuroQol Visual Analogue Scale |
EQ-5D-VAS |
UK |
Patients with psychosis |
172 |
Pearson coefficient |
0.52 |
[19] |
OxCAP-MH |
Brief Psychiatric Rating Scale (negative correlation) |
BPRS* |
UK |
Patients with psychosis |
172 |
Pearson coefficient |
0.41 |
[19] |
OxCAP-MH |
Global Assessment of Functioning |
GAF |
UK |
Patients with psychosis |
172 |
Pearson coefficient |
0.24 |
[19] |
OxCAP-MH |
Objective Social Outcomes Index |
SIX |
UK |
Patients with psychosis |
172 |
Pearson coefficient |
0.12 |
[19] |
Women’s Capabilities Index |
WHOQOL-Bref |
WHOQOL-Bref |
Malawi |
Women from Mchinji, Malawi |
20 |
Pearson correlation |
0.62 |
[64] |